Anti-Mouse CD152 (CTLA-4) – DyLight® 488

Anti-Mouse CD152 (CTLA-4) – DyLight® 488

Product No.: C1748

[product_table name="All Top" skus="C1748"]

- -
- -
Clone
9H10
Target
CTLA-4
Formats AvailableView All
Product Type
Monoclonal Antibody
Alternate Names
CD152, Cytotoxic T Lymphocyte-Associated Antigen-4, Ly-56
Isotype
IgG
Applications
FC

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Syrian Hamster
Immunogen
Purified Recombinant Mouse CTLA-4 (>98%)
Product Concentration
0.2 mg/ml
Formulation
This DyLight® 488 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Storage and Handling
This DyLight® 488 conjugate is stable when stored at 2-8°C. Do not freeze.
Country of Origin
USA
Shipping
Next Day 2-8°C
Excitation Laser
Blue Laser (493 nm)
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
Clone 9H10 recognizes an epitope on mouse CTLA-4.
Background
CTLA-4 is a 33 kD member of the Ig superfamily similar to CD28 in amino acid sequence, structure, and genomic organization. CTLA-4 is a protein receptor that functions as an immune checkpoint and downregulates immune responses. It is involved in the development of protective immunity and thymocyte regulation, in addition to the induction and maintenance of immunological tolerance. CTLA-4 has therapeutic potential both as an agonist to reduce immune activity, and an antagonist to increase immune activity.
Antigen Distribution
CTLA-4 is expressed on activated T and B lymphocytes.
Ligand/Receptor
CD80 (B7-1), CD86 (B7-2)
Function
Negative regulator of T cell activation
PubMed
NCBI Gene Bank ID
Research Area
Immunology

References & Citations

Flow Cytometry

Certificate of Analysis

Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.